Activity of caffeic acid derivatives against Candida albicans biofilm

Bioorganic and Medicinal Chemistry Letters

Volumn 24, Issue 6, 2014, Pages 1502-1505

  De Vita, Daniela ^a   Friggeri, Laura ^a   D'Auria, Felicia Diodata ^a   Pandolfi, Fabiana ^a   Piccoli, Francesco ^a   Panella, Simona ^a   Palamara, Anna Teresa ^a   Simonetti, Giovanna ^a   Scipione, Luigi ^a   Di Santo, Roberto ^a   Costi, Roberta ^a   Tortorella, Silvano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anti biofilm agents; Biofilm formation; Caffeic acid; Candida albicans biofilm

Indexed keywords

3,4 DIHYDROXYBENZOIC ACID ESTER; ALCOHOL; CAFFEIC ACID DERIVATIVE; CAFFEIC ACID ESTER; CARBOXYL GROUP; CINNAMIC ACID ESTER; ESTER DERIVATIVE; FLUCONAZOLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CARCINOMA CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

CANDIDA ALBICANS;

ANTI-BIOFILM AGENTS; BIOFILM FORMATION; CAFFEIC ACID; CANDIDA ALBICANS BIOFILM;

ANTIFUNGAL AGENTS; BIOFILMS; CAFFEIC ACIDS; CANDIDA ALBICANS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84895795071     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2014.02.005     Document Type: Article

References (20)

1. C.A. Kumamoto Curr. Opin. Microbiol. 5 2002 608
2. E.M. Kojic, and R.O. Darouiche Clin. Microbiol. Rev. 17 2004 255
3. G. Ramage, J.P. Martinez, and J.L. Lopez-Ribot FEMS Yeast Res. 6 2006 979
4. M. Tumbarello, B. Posteraro, E.M. Trecarichi, B. Fiori, M. Rossi, R. Porta, K.D.G. Donati, M. La Sorda, T. Spanu, G. Fadda, R. Cauda, and M. Sanguinetti J. Clin. Microbiol. 45 2007 1843
5. L.A. Murillo, G. Newport, C.Y. Lan, S. Habelitz, J. Dungan, and N.M. Agabian Eukaryot. Cell 4 2005 1562
6. R.M. Donlan, and J.W. Costerton Clin. Microbiol. Rev. 15 2002 167
7. P.K. Mukherjee, and J. Chandra Drug Resist. Updat. 7 2004 301
8. G. Ramage, S. Bachmann, T.F. Patterson, B.L. Wickes, and J.L. López-Ribot J. Antimicrob. Chemother. 49 2002 973
9. S. Bhattacharyya, P. Gupta, G. Banerjee, A. Jain, and M. Singh Int. J. Curr. Res. Rev. 05 2013 31
10. Tsai, Y.; Lee, M.; Hsu, C.; Chuang, K. U.S. Patent 20,100,331,409 A1, 2010.
11. C. Messier, F. Epifano, S. Genovese, and D. Grenier Phytomedicine 18 2011 380
12. J. Breger, B.B. Fuchs, G. Aperis, T.I. Moy, F.M. Ausubel, and E. Mylonakis PLoS Pathog. 3 2007 e18
13. D.I. Edwards Comprehensive Medicinal Chemistry P.G. Sammes, J.B. Taylor, The Rational Design, Mechanistic Study and Therapeutic Application of Chemical Compounds 1990 Pergamon Oxford 725 751
14. S.M. Fiuza, C. Gomes, L.J. Teixeira, M.T. Girão da Cruz, M.N. Cordeiro, N. Milhazes, F. Borges, and M.P. Marques Bioorg. Med. Chem. 12 2004 3581
15. Prasad, R.; Conrad, J. P.; Ilg, T. J. U.S. Patent 7,368,593 (B1), 2008.
16. J.P. Parrish, E.E. Dueno, S. Kim, and K.W. Jung Synth. Commun. 30 2000 2687
17. Brewster, A. G.; Caulkett, P. W. R.; Faull, A. W.; Pearce, R. J.; Shute, R. E. US Patent 5,612,373 A1, 1997.
18. Clinical and Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard Document M27-A3 3rd ed. 2008 CLSI Wayne, PA
19. C.G. Pierce, P. Uppuluri, A.R. Tristan, F.L. Wormely Jr., E. Mowat, G. Ramage, and J.L. Lopez-Ribot Nat. Protoc. 3 2008 1494
20. T. Mosmann J. Immunol. Methods 65 1983 55